VEGFA rs3025039 is associated with phenotype severity of myelofibrosis-type megakaryocyte dysplasia

EJHaem. 2023 May 7;4(3):756-759. doi: 10.1002/jha2.708. eCollection 2023 Aug.

¹ Center for the Study of Myelofibrosis General Medicine 2 Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation Pavia Italy.
² Center for Systemic Amyloidoses and High Complexity Diseases General Medicine 2 Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation Pavia Italy.
³ Biometry and Clinical Epidemiology Scientific Direction Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation Pavia Italy.
⁴ Department of Immunology and Inflammation Centre for Haematology Research Imperial College London London UK.

No abstract available